Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.europeanpharmaceuticalreview.com/news/174730/car-t-therapy-safe-for-relapsed-or-refractory-t-cell-malignancies-finds-study/
https://www.biospace.com/article/releases/bioheng-biotech-announces-publication-of-impressive-results-with-cd7-targeted-allogeneic-car-t-cell-therapy-for-relapsed-or-refractory-t-cell-malignancies/
https://www.prnewswire.com/news-releases/ctb001-bioheng-auto-car---t-product-received-orphan-drug-designation-odd-from-the-us-fda-301470432.html